Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Alterome Therapeutics, Inc.
Nuvectis Pharma, Inc.
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Janssen Research & Development, LLC
Angiex, Inc.
Werewolf Therapeutics, Inc.
Adaptimmune
Bristol-Myers Squibb
Novartis
OncoNano Medicine, Inc.
Calico Life Sciences LLC
Celgene
GlaxoSmithKline
Sairopa B.V.
Bristol-Myers Squibb
AstraZeneca
Coherus Oncology, Inc.
St. Jude Children's Research Hospital
Rondo Therapeutics
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
Nurix Therapeutics, Inc.
Kazia Therapeutics Limited
Pfizer
Exelixis
Trishula Therapeutics, Inc.
Peking University First Hospital
Trishula Therapeutics, Inc.
DEKA Biosciences
Revolution Medicines, Inc.
Endocyte
LaunXP Biomedical Co., Ltd.
Poseida Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Exelixis
Eli Lilly and Company
Emory University
Optimal Health Research
Ultimovacs ASA
Bayer
Ikena Oncology
AO GENERIUM